Back to top

Analyst Reiterates Buy on Wave’s WVE-007, Maintaining Unchanged $13 Price Target Amid Enhanced Phase 2a INLIGHT Design

H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Wave Life Sciences today and set a price target of $13.00. Andrew Fein has given his...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

WAVE Life Sciences Ltd. (WVE)